Ken Valenzano, VP, Pharmacology & Biology at AMICUS THERAPEUTICS INC (FOLD), sold 7,751 shares at $11.68 ($91K) on 2015-03-20, disclosed to the SEC on 2015-03-25.
Scheduled sale ($91k) by VP, Pharmacology & Biology under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.68 | 6,043 | $71K | 77.3% |
| 2 | $12.11 | 1,708 | $21K | 22.7% |
| Total | $11.77 avg | 7,751 | $91K | 100% |
| Filing → |
| FOLD | SELL | 2015-05-12 | $141K | — | Filing → |
| FOLD | SELL | 2015-04-17 | $63K | — | Filing → |
| FOLD | SELL | 2015-03-24 | $150K | — | Filing → |